| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8232011 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 8 Pages |
Abstract
It is feasible and safe to deliver single-fraction, high-dose SBRT to primary or metastatic liver malignancies measuring â¤5 cm. Moreover, single-fraction SBRT for liver lesions demonstrated promising local tumor control with minimal acute and long-term toxicity. Single-fraction SBRT appears to be a viable nonsurgical option, but further studies are warranted to evaluate both control rates and impact on quality of life.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Karyn A. M.D., Ellen A. M.D., Katherine E. M.D., Zhigang Ph.D., Qianxing Ph.D., George M.D., Iris C. M.D., George A. M.D., Ph.D., Albert C. M.D., Ph.D.,